Le Lézard
Classified in: Science and technology
Subject: PARTNERSHIPS

eLichens is introducing the first Natural Gas Detector integrating NB-IoT/LTE-M Connectivity from Sequans


GRENOBLE, France, Sept. 05, 2023 (GLOBE NEWSWIRE) -- eLichens, a leading provider of non-dispersive infrared sensors and detectors, is thrilled to announce the collaboration with Sequans, resulting in the latest evolution of its Avolta, Natural Gas Detector (NGD). This new edition of Avolta harnesses the power of NB-IoT/LTE-M technology, utilizing the Sequans' Monarch-2 platform.

Avolta is a battery-operated NGD device with a longevity of 10 years. Avolta offers near-infrared spectroscopy to detect methane's unique signature on the light spectrum, delivering unparalleled accuracy while effectively mitigating the risk of interference from other household chemicals.

The core mission of Avolta is to drive a significant reduction in methane emissions, safeguard the future of energy resources, and ensure the safety of individuals and the environment.

Avolta becomes an essential part of the net zero program that is reshaping the global economy.

"Accelerating the deployment of natural gas detection across the entire energy value chain is an essential part of global efforts to reduce greenhouse gas emissions," said Wahid Issa, eLichens CEO. "Avolta integrating Sequans' Monarch-2 connectivity enables gas utilities to deploy ubiquitous NGD at an optimized cost of ownership, and ensures compliance with FirstNet certification and standards such as UL1484 and EN50194-1."

"Monarch-2 GM02S is a LTE Cat M1/NB1/NB2 module based on Sequans' second-generation Monarch 2 chipset platform. Monarch 2 includes Sequans' RF Single-SKUtm front end and incorporates the Common Criteria EAL5+ secure enclave, enabling secure key storage and embedded SIM (iSIM)," said Georges Karam, CEO and President of Sequans.

For more information on Avolta: www.elichens.com/avolta-gas-leak-detector

About eLichens        
eLichens mission is to provide solutions for detecting and monitoring climate issues related to environmental greenhouse gases. eLichens relies on a portfolio of patents and expertise that allow it to develop innovative and disruptive smart infra-red sensors and industrial IOT devices. eLichens is based in Grenoble, France with offices in the USA. Visit www.elichens.com

Contact: [email protected]

About Sequans        
Sequans Communications S.A. (NYSE: SQNS) is a leading developer and supplier of cellular IoT connectivity solutions, providing chips and modules for 5G/4G massive and broadband IoT. Founded in 2003, Sequans is based in Paris, France with offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Finland, Taiwan, South Korea, and China. Visit Sequans online at www.sequans.com, and follow us on Twitter and Linked-In.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bd8a6db5-ae53-4d61-ae85-7108ba3d68b7



These press releases may also interest you

at 08:55
Omeros Corporation , today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market closes. Omeros management will host a conference call and webcast that...

at 08:53
When walking into the factory of auto parts maker Bosa in Peng'an county, Sichuan province, people must be amazed by how efficiently robots weld on the production line....

at 08:51
VMS BioMarketing today announced that its OneVoicetm solution has been selected as winner of the "Best Patient Relationship Management Solution" award in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an...

at 08:42
In a move that aligns with the growing concerns over disposable vapes, the innovative e-liquid brand DELICIU made its debut at the Vaper Expo UK on May 10th. This launch is especially timely, as the UK and several European countries are considering...

at 08:40
The "Cell and Gene Therapies in CNS Disorders" report has been added to ResearchAndMarkets.com's offering. The analyst anticipates that the global CGT market value in CNS disorders will experience significant growth - sales are expected to increase...

at 08:38
On September 23, 2007, Dr. Shanea Clancy's life took a dramatic turn, when at 21 years of age, she found herself embroiled in a nationally covered, unprecedented EMS case where she was driving an ambulance that was involved in a crash that killed two...



News published on and distributed by: